F. DEMİRKAN Et Al. , "COMPARING THE EFFICACY OF GENERIC IMATINIB FORMULATIONS WITH THE ORIGINAL IMATINIB AS ATHE FRONTLINE TYROSINE KINASE IN CRONIC PHASE CHRONIC MYELOID LEUKEMIA," ASCO ANNUAL MEETING 2015 , United States Of America, 2015
DEMİRKAN, F. Et Al. 2015. COMPARING THE EFFICACY OF GENERIC IMATINIB FORMULATIONS WITH THE ORIGINAL IMATINIB AS ATHE FRONTLINE TYROSINE KINASE IN CRONIC PHASE CHRONIC MYELOID LEUKEMIA. ASCO ANNUAL MEETING 2015 , (United States Of America).
DEMİRKAN, F., SEVİNDİK, Ö. G., KARAMAN, A., ALACACIOĞLU, İ., MEDENİ SOLMAZ, Ş., & ÖZSAN, G. H., (2015). COMPARING THE EFFICACY OF GENERIC IMATINIB FORMULATIONS WITH THE ORIGINAL IMATINIB AS ATHE FRONTLINE TYROSINE KINASE IN CRONIC PHASE CHRONIC MYELOID LEUKEMIA . ASCO ANNUAL MEETING 2015, United States Of America
DEMİRKAN, FATİH Et Al. "COMPARING THE EFFICACY OF GENERIC IMATINIB FORMULATIONS WITH THE ORIGINAL IMATINIB AS ATHE FRONTLINE TYROSINE KINASE IN CRONIC PHASE CHRONIC MYELOID LEUKEMIA," ASCO ANNUAL MEETING 2015, United States Of America, 2015
DEMİRKAN, FATİH Et Al. "COMPARING THE EFFICACY OF GENERIC IMATINIB FORMULATIONS WITH THE ORIGINAL IMATINIB AS ATHE FRONTLINE TYROSINE KINASE IN CRONIC PHASE CHRONIC MYELOID LEUKEMIA." ASCO ANNUAL MEETING 2015 , United States Of America, 2015
DEMİRKAN, F. Et Al. (2015) . "COMPARING THE EFFICACY OF GENERIC IMATINIB FORMULATIONS WITH THE ORIGINAL IMATINIB AS ATHE FRONTLINE TYROSINE KINASE IN CRONIC PHASE CHRONIC MYELOID LEUKEMIA." ASCO ANNUAL MEETING 2015 , United States Of America.
@conferencepaper{conferencepaper, author={FATİH DEMİRKAN Et Al. }, title={COMPARING THE EFFICACY OF GENERIC IMATINIB FORMULATIONS WITH THE ORIGINAL IMATINIB AS ATHE FRONTLINE TYROSINE KINASE IN CRONIC PHASE CHRONIC MYELOID LEUKEMIA}, congress name={ASCO ANNUAL MEETING 2015}, city={}, country={United States Of America}, year={2015}}